Helgi van de Velde
Company: Sanofi
Job title: Vice President, Head of Hematologic Malignancies Strategies and Late Development
Seminars:
Case Study: Developing Effective Innate Cell Engager Strategies in Haematological Malignancies 9:30 am
Dual NK cell engagement to enhance antitumoural activity Trifunctional NK cell engager in AML Trifunctional NK cell engager in multiple myelomaRead more
day: Conference Day Two